Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilar…
Oct 27, 2018
onclive.com
1.7K views · 26 reactions | What promises do biosimilar products offer? Watch this video with FDA Commissioner Dr. Scott Gottlieb and Dr. Leah Christl to learn more. https://go.usa.gov/xQyRZ | U.S. Food and Drug Administration | Facebook
0:14
1.7K views · 26 reactions | What promises do biosimilar products o…
1.7K views2 weeks ago
FacebookU.S. Food and Drug Administration
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated results of the randomized, phase 3 study DESTINY-Breast03 | OncLive
Trastuzumab deruxtecan versus trastuzumab emtansine in patient…
Dec 22, 2022
onclive.com
Dr. Hurvitz on Biosimilars in Breast Cancer | OncLive
Dr. Hurvitz on Biosimilars in Breast Cancer | OncLive
Apr 23, 2018
onclive.com
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer…
Aug 5, 2022
mskcc.org
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Aug 23, 2019
onclive.com
Dr. Kolberg on Collecting Real-World Biosimilar Trastuzumab Data in Breast Cancer | OncLive
Dr. Kolberg on Collecting Real-World Biosimilar Trastuzumab Dat…
Sep 4, 2019
onclive.com
Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Br…
1 month ago
onclive.com
4:01
Trastuzumab deruxtecan: a promising agent for treating HER…
1.7K viewsMay 5, 2021
YouTubeVJOncology
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K viewsMar 27, 2018
YouTubeOncLive
Biosimilar medicines: Overview | European Medicines Agency (EMA)
Dec 5, 2023
europa.eu
HER2CLIMB-05: tucatinib with trastuzumab and pertuzumab as …
1.2K viewsJun 14, 2022
YouTubeVJOncology
Clinical usage of antibody: Herceptin (Antibody as breast can…
14.1K viewsJun 11, 2018
YouTubeAnimated biology With arpan
What is a biosimilar? What is interchangeability? | The Biosimil…
Nov 15, 2019
biosimilarscouncil.org
#Biosimilars in cancer: trastuzumab, bevacizumab, rituximab, epoetina…
30.2K viewsJul 10, 2023
YouTubeConsejo General de Colegios Farmacéuticos
5:40
Trastuzumab deruxtecan doubles PFS in metastatic breast cancer wi…
821 viewsJun 15, 2022
YouTubeecancer
5:26
Trastuzumab deruxtecan shows benefit in patients with HER2 + mBC
816 viewsMay 17, 2023
YouTubeecancer
4:20
The Biosimilar Development Process
41K viewsMay 22, 2018
YouTubeU.S. Food and Drug Administration
38:15
Biosimilars and Biologics
30K viewsOct 30, 2013
YouTubeClevelandClinicCME
5:20
Data Requirements for Biosimilars
28.8K viewsMay 22, 2018
YouTubeU.S. Food and Drug Administration
4:20
The Concept of Interchangeability
24.5K viewsMay 22, 2018
YouTubeU.S. Food and Drug Administration
3:20
How Monoclonal Antibodies Treat Cancer
168.3K viewsJun 30, 2020
YouTubeNational Cancer Institute
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
503 viewsJul 7, 2020
YouTubeTargeted Oncology
3:09
Biosimilars vs. Generic drugs
5K viewsJun 20, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
13:36
Pharmacology - CANCER DRUGS – CELL CYCLE INHIBITORS (MADE …
212.5K viewsMar 1, 2020
YouTubeSpeed Pharmacology
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
162.9K viewsApr 30, 2013
YouTubeHMP Education
3:00
Biosimilars: complex copycat drugs
24.7K viewsMay 8, 2019
YouTubenature video
0:34
Herceptin: Mechanism of action
52.3K viewsAug 2, 2007
YouTubeCancerQuest
6:18
FDA Approves of Biosimilar to Infliximab – IBD in the News
2.9K viewsMay 6, 2016
YouTubeMayo Clinic
1:31
Current Treatment Options for Patients With HER2-Positive Meta…
3.3K viewsApr 1, 2019
YouTubeTargeted Oncology
See more videos
Static thumbnail place holder